$5 million gift from The Bob & Renee Parsons Foundation expands capacity for therapy, research, and training on psychedelic-assisted therapy
Renowned expert in building global health partnerships and HIV care to speak at the 2024 Concordia Annual Summit
A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), establishes the first Undiagnosed Diseases Network (UDN) site in the New York metropolitan area.
Mount Sinai Health System today announced that they will be among the first in the world to deploy blood-based biomarkers (blood tests) and confirmatory tests for Alzheimer’s disease and related dementias to patients across primary and specialty care settings—early detection tools that have never before been offered to patients in the clinical setting—as part of the Davos Alzheimer’s Collaborative (DAC) Healthcare System Preparedness Accurate Diagnosis project.
Mount Sinai study could lead to new treatments for fibromuscular dysplasia
Mount Sinai Health System and IBM Research today announced the launch of the Phenotypes Reimagined to Define Clinical Treatment and Outcome Research (PREDiCTOR) study. The research effort aims to address the lack of objective measures in psychiatry by leveraging advances in artificial intelligence and incorporating rich behavioral data from clinical interviews, at-home data captured on smartphones, and cognitive testing.
Mount Sinai Health System has appointed Lisa S. Stump, MS, FASHP, as Chief Digital Information Officer of the Mount Sinai Health System and Dean for Information Technology (IT) of the Icahn School of Medicine at Mount Sinai. She will serve as a key bridge between the clinical, educational, and research missions of the Health System as she leads the effort to further strengthen Mount Sinai’s digital strategy.
A novel study by researchers at the Icahn School of Medicine at Mount Sinai addresses a critical yet under-explored question in cancer research: Why is aging the biggest risk factor for cancer? The study reveals how an aging immune system spurs tumor growth, offering new insights into cancer prevention and treatment, especially for older adults.
Researchers at the Icahn School of Medicine at Mount Sinai have developed a noninvasive technique that could dramatically improve the way doctors monitor intracranial hypertension, a condition where increased pressure in the brain can lead to severe outcomes like strokes and hemorrhages.
The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.
Investigating a new frontier in understanding diseases like obesity and type 2 diabetes.
Scientists at the Icahn School of Medicine at Mount Sinai have identified a new class of RNAs packed into tiny particles known as extracellular vesicles (EVs) that could revolutionize how cancer and other diseases are diagnosed. The team found that these molecules undergo changes when cancer is present, suggesting their potential as biomarkers for detecting prostate cancer or as targets for therapy.
Mount Sinai is celebrating its 12th year as the official hospital and medical services provider of the US Open Tennis Championships, which begins with Fan Week August 19-25 and continues with the Main Draw August 26-September 8. It is also Mount Sinai’s 10th year in this capacity for the U.S. Teams for the Billie Jean King Cup and Davis Cup events.
The Icahn School of Medicine at Mount Sinai, a top ranked medical school in the U.S., known for its strong culture of innovation and scholarship, is launching a re-envisioned curriculum for MD students.
A new study determines incidence of and risk factors for hepatitis C virus reinfection among men with HIV, and offers new insight on transmission.
The American Society of Retina Specialists is honoring Richard B. Rosen, MD, ScD (hon), FACS, FASRS, FARVO, CRA, the Belinda Bingham Pierce and Gerald G. Pierce Distinguished Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, with the prestigious Founders Award for 2024.
The Mount Sinai Hospital, the flagship hospital of Mount Sinai Health System, was listed among the nation’s top hospitals for care excellence by U.S. News & World Report®, marking the ninth straight year the hospital has been listed among the top 20 in the country on the publication’s “Honor Roll.”
Ramaiah Memorial Hospital (RMH), one of India's leading multi-super-specialty quaternary care hospitals based at Bengaluru, Karnataka, has signed an exclusive agreement with the New York-based Mount Sinai Health System today, marking the beginning of a transformative partnership that aims at advancing healthcare services through collaborations in clinical excellence, quality of care, research, innovation and technology.
First-of-its-kind clinical trial with specific JAK inhibition will investigate the best treatment for inflammatory skin conditions in these patients
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right